Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemiaHeikki Kuusanmäki, Caroline A. Heckman|Haematologica|2019Cited by 184
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemiaHeikki Kuusanmäki, Satu Mustjoki|Blood|2022Cited by 123
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signalingHeikki Kuusanmäki, Caroline A. Heckman|Oncotarget|2017Cited by 31
Functional drug response profiling predicts clinical outcomes and shows utility for treatment stratification in AMLAleksej Drino, Nikolaus Krall, P Kovács et al.|Blood|2025Cited by 0